Another possibility is that different therapeutic approaches may be appropriate in PCa, perhaps those that focus on mobilizing B cells or activate T cells by mechanisms that do not involve inhibition of PD-1-PD-L1 binding. This evidence concerns the gene CD274 and posterior cortical atrophy.